Realbotix Corp. XBOTF
—
0.19
0.00
0.00%
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow XBOTF
| Sep '23 | Sep '24 | Sep '25 | |
|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 |
P/S ratio |
42.99 | 13.53 | 36.45 |
P/FCF ratio |
0.00 | 0.00 | 43.74 |
P/Operating CF |
(5.05) | (11.53) | (33.24) |
P/B ratio |
1.29 | 1.54 | 20.04 |
Price to Tangible BV |
2.99 | 1.88 | 28.26 |
EV/Sales |
29.96 | 13.59 | 34.39 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
(2.49) | (3.05) | (12.78) |
EV/FCF |
(3.89) | (4.52) | 41.26 |
Quick Ratio |
4.01 | 0.55 | 2.22 |
Current Ratio |
4.12 | 0.72 | 2.43 |
Net Debt/EBITDA |
2.69 | (0.02) | 0.75 |
Debt/Assets |
0.00% | 12.29% | 14.59% |
Debt/Equity |
0.00 | 0.19 | 0.28 |
Asset Turnover |
0.00 | 0.08 | 0.21 |
Operating CF/Net income |
0.33 | 0.48 | 1.13 |
Capex/Depreciation |
0.00 | 3.31 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| 0.00% | (101.07%) | (82.19%) | |
| 0.00% | (77.55%) | (49.73%) | |
ROIC |
(14.94%) | (28.05%) | 0.00% |
Return on Tangible Assets |
(348.75%) | 3,402.47% | (132.05%) |
Average Days of Receivables |
121.21 | 16.24 | 24.94 |
Research and Development Expense of Revenue |
0.00% | 39.19% | 37.91% |
Selling, General and Administrative Expense of Revenue |
434.22% | 135.98% | 84.83% |
Intangible Assets out of Total Assets |
0.00 | 0.12 | 0.15 |
Share Based Compensation of Revenue |
55.63% | 31.45% | 20.49% |
Graham Net Nets |
0.24 | (0.18) | 0.03 |
Graham Number |
0.00 | 0.00 | 0.00 |
Earnings Yield |
(89.36%) | (89.13%) | (6.73%) |
Free Cash Flow Yield |
(17.93%) | (22.22%) | 2.29% |
Revenue per Share |
0.00 | 0.01 | 0.01 |
Operating CF per Share |
(0.03) | (0.03) | (0.03) |
Capex per Share |
0.01 | 0.01 | 0.00 |
Free Cash Flow per Share |
(0.02) | (0.02) | (0.03) |
Cash per Share |
0.03 | 0.01 | 0.03 |
Shareholders Equity per Share |
0.09 | 0.05 | 0.02 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
0.09 | 0.05 | 0.02 |
Free Cash Flow |
(2.07) | (2.74) | (5.42) |
Working Capital |
2.79 | (0.75) | 3.41 |
Capital Expenditures |
1.16 | 1.32 | — |
Net Current Asset Value |
2.74 | (2.25) | 2.38 |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
(4.33) | (1.45) | 0.00 |
Net Profit Margin |
(3,630.78%) | (937.78%) | (238.22%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
— | 0.80 | 3.00 |
Cash ROIC |
(25.98%) | (41.72%) | (57.03%) |
Accounts Receivable Turnover |
0.00 | 14.08 | 22.60 |
Accounts Payable Turnover |
0.00 | 1.01 | 2.57 |
Inventory Turnover |
0.00 | 0.00 | 3.46 |
Average Days of Payables |
138.34 | 358.76 | 85.00 |
Days of Inventory on Hand |
0.00 | 196.39 | 102.45 |
Average Receivables |
— | 0.06 | 0.09 |
Average Payables |
— | 0.72 | 0.51 |
Average Inventory |
— | — | 0.38 |
Average Assets |
— | 11.03 | 9.65 |
Average Common Equity |
— | 8.47 | 5.84 |
Columns are period end dates · fundamentals updated 24 Sep 2026